News Related to Supernus Pharmaceuticals Inc.

Related coverage linked through entity extraction aliases.

Encephalitis Global Clinical Trials Review 2025 Report Released

Feb 19, 2026

A comprehensive report on encephalitis clinical trials has been added to ResearchAndMarkets.com's offering, providing data on trial numbers, enrollment trends, and geographic distribution across G7 and E7 countries.

Late-Stage CNS and Oncology Assets Drive Biotech M&A Strategy Shift

Feb 17, 2026

Pharmaceutical companies are prioritizing de-risked, late-stage assets with human clinical validation over early-stage programs. Oncology and CNS programs have emerged as strategic M&A targets due to large commercial markets and significant unmet medical needs.